Scleroderma associated with ANCA-associated vasculitis

Rheumatology International

Volumn 26, Issue 5, 2006, Pages 369-375

  Young, Hee Rho ^a   Seong, Jae Choi ^b   Young, Ho Lee ^b   Jong, Dae Ji ^a   Song, Gwan Gyu ^b  

^a College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

ANCA; Scleroderma; Vasculitis

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DNA TOPOISOMERASE; PENICILLAMINE; STEROID;

ANCA ASSOCIATED VASCULITIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG INDUCED DISEASE; DRUG SAFETY; HUMAN; KAPLAN MEIER METHOD; KIDNEY FUNCTION TEST; KOREA; MULTIVARIATE ANALYSIS OF COVARIANCE; PAGET SKIN DISEASE; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCLERODERMA; SIDE EFFECT; STATISTICAL ANALYSIS; SURVIVAL; WEGENER GRANULOMATOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SEX FACTORS; VASCULITIS;

EID: 33644629873     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-005-0011-5     Document Type: Review

References (44)

1. Endo H, Hosono T, Kondo H (1994) Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 21:864-870
2. Akimoto S, Ishikawa O, Tamura T, Miyachi Y (1996) Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis. Br J Dermatol 134:407-410
3. Kiraz S, Simsek H, Ertenli I, Benekli M, Kadayifci A (1996) Antineutrophil cytoplasmic antibodies in systemic sclerosis. Clin Rheumatol 15:519-520
4. Locke IC, Worrall JG, Leaker B, Black CM, Cambridge G (1997) Autoantibodies to myeloperoxidase in systemic sclerosis. J Rheumatol 24:86-89
5. Bellisai F, Morozzi G, Bacarelli MR, Radice A, Sinico RA, Wieslander J, Sebastiani GD, Campanella V, Marcolongo R, Galeazzi M (2001) Anti-proteinase 3 antibodies in diffuse systemic sclerosis (SSc) with normotensive renal impairment: is it suggestive for an overlapping between SSc and idiopathic vasculitis? Reumatismo 53:33-39
6. Casari S, Haeney M, Farrand S, Herrick A (2002) Antineutrophil cytoplasmic antibodies a "Red Flag" in patients with systemic sclerosis. J Rheumatol 29:2666-2667
7. Caramaschi P, Biasi D, Tonolli E, Carletto A, Bambara LM (2002) Antineutrophil cytoplasmic antibodies in scleroderma patients: first report of a case with anti-proteinase 3 antibodies and review of the literature. Joint Bone Spine 69:177-180
8. Ruffatti A, Sinico RA, Radice A, Ossi E, Cozzi F, Tonello M, Grypiotis P, Todesco S (2002) Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis. J Rheumatol 29:918-923
9. Rho YH, Choi SJ, Ji JD, Lee YH, Song GG (2005) Scleroderma associated with ANCA-associated vasculitis. A case report. Rheumatol Int (in submission). DOI 10.1007/s00296-005-0003-5
10. Le Thi Huong D, Gatfosse M, Papo T, Beaufils H, Faucher C, Frances C, Godeau P (1994) Wegener's granulomatosis and CREST syndrome. Br J Rheumatol 33:1087-1088
11. Kobayashi M, Saito M, Minoshima S, Arimura Y, Nagasawa T (1995) A case of progressive systemic sclerosis with crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) and anti-glomerular basement membrane antibody (anti-GBM Ab). Nippon Jinzo Gakkai Shi 37:207-211
12. Vazquez-Del Mercado M, Mendoza-Topete A, Best-Aguilera CR, Garcia-De La Torre I (1996) Diffuse alveolar hemorrhage in limited cutaneous systemic sclerosis with positive perinuclear antineutrophil cytoplasmic antibodies. J Rheumatol 23:1821-1823
13. Carvajal I, Bernis C, Sanz P, Garcia A, Garcia-Vadillo A, Traver JA (1997) Antineutrophil cytoplasmic autoantibodies (ANCA) and systemic sclerosis. Nephrol Dial Transplant 12:576-577
14. Hillis GS, Khan IH, Simpson JG, Rees AJ (1997) Scleroderma, D-penicillamine treatment, and progressive renal failure associated with positive antimyeloperoxidase antineutrophil cytoplasmic antibodies. Am J Kidney Dis 30:279-281
15. Karpinski J, Jothy S, Radoux V, Levy M, Baran D (1997) D-penicillamine-induced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma. Case report and review of the literature. Am J Nephrol 17:528-532
16. Omote A, Muramatsu M, Sugimoto Y, Hosono S, Murakami R, Tanaka H, Watanabe Y, Sano H, Kato K (1997) Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies-related scleroderma renal crisis treated with double-filtration plasmapheresis. Intern Med 36:508-513
17. Uriuhara A, Morita S, Yamada K, Masugi J, Yamada H, Hasegawa Y, Yokono K, Kasuga M (1997) A case of MPO-ANCA positive progressive systemic sclerosis with status epileptics. Ryumachi 37:483-486
18. Marchand-Courville S, Dhib M, Fillastre JP, Godin M (1998) Extracapillary glomerulonephritis secondary to D-penicillamine. Apropos of 1 case and review of the literature. Nephrologie 19:25-32
19. Anders HJ, Wiebecke B, Haedecke C, Sanden S, Combe C, Schlondorff D (1999) MPO-ANCA-Positive crescentic glomerulonephritis: a distinct entity of scleroderma renal disease? Am J Kidney Dis 33:e3
20. Harashima S, Yoshizawa S, Horiuchi T, Nakashima H, Niho Y, Kusaba T, Hayashida I, Shinozaki M, Katafuchi R, Hirakata H (1999) A case of systemic sclerosis with crescentic glomerulonephritis associated with perinuclear-antineutrophil cytoplasmic antibody (p-ANCA). Nihon Rinsho Meneki Gakkai Kaishi 22:86-92
21. Katrib A, Sturgess A, Bertouch JV (1999) Systemic sclerosis and antineutrophil cytoplasmic autoantibody-associated renal failure. Rheumatol Int 19:61-63
22. Kyndt X, Ducq P, Bridoux F, Reumaux D, Makdassi R, Gheerbrant JD, Vanhille P (1999) Extracapillary glomerulonephritis with anti-myeloperoxidase antibodies in 2 patients with systemic scleroderma treated with penicillamine D. Presse Med 28:67-70
23. Villaverde V, Balsa A, Cabezas JA, Fernandez-Prada M, Torre A, Mola EM (1999) Normotensive renal failure in a patient with systemic sclerosis and p-antineutrophil cytoplasmic autoantibodies which developed into Paget's disease of bone after immunosuppressive therapy. Rheumatology (Oxford) 38:190-191
24. Maes B, Van Mieghem A, Messiaen T, Kuypers D, Van Damme B, Vanrenterghem Y (2000) Limited cutaneous systemic sclerosis associated with MPO-ANCA positive renal small vessel vasculitis of the microscopic polyangiitis type. Am J Kidney Dis 36:E16
25. Martinez Ara J, Picazo ML, Torre A, Pascual D, Diaz Rodriguez C, Rinon C (2000) Progressive systemic sclerosis associated with anti-myeloperoxidase ANCA vasculitis with renal and cutaneous involvement. Nefrologia 20:383-386
26. Mizutani A, Tanaka I, Katayama M, Oshima H, Komatsu Y, Asano S, Kato K, Matsumura H, Ishii K, Miyama H, Nagai T, Fukaya S, Yoshida S, Hasegawa M, Kawashima S, Torikai K (2000) A case of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis associated with systemic sclerosis treated by steroid pulse therapy: a case report. Ryumachi 40:828-832
27. Yamashita K, Yorioka N, Kyuden Y, Naito T, Tanji C, Ueda C, Usui K, Shigemoto K, Harada S, Yamakido M (2000) A case of CREST syndrome and myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis. Clin Nephrol 53:296-300
28. Wutzl AL, Foley RN, O'Driscoll BR, Reeve RS, Chisholm R, Herrick AL (2001) Microscopic polyangiitis presenting as pulmonary-renal syndrome in a patient with long-standing diffuse cutaneous systemic sclerosis and antibodies to myeloperoxidase. Arthritis Rheum 45:533-536
29. Kumakura S, Ishikura H, Kondo M, Murakawa Y, Kobayashi S (2002) Hemophagocytosis associated with MPO-ANCA positive vasculitis in systemic sclerosis. Clin Exp Rheumatol 20:411-414
30. Miyamura T, Yamamoto M, Shimada H, Suematsu E (2002) Systemic sclerosis associated with microscopic polyangitis presenting with high myeloperoxidase (MPO) titer and necrotizing angitis: a case report. Ryumachi 42:910-914
31. Miyata N, Kobayashi T, Matsukawa Y, Sawada S, Nishinarita S, Horie T (2002) Anti-neutrophil cytoplasmic autoantibody-associated rapid progressive glomerulonephritis complicated with both limited and diffuse scleroderma. Nihon Rinsho Meneki Gakkai Kaishi 25:473-479
32. Tomioka M, Hinoshita F, Miyauchi N, Akiyama Y, Saima S, Hiroe M (2004) ANCA-related crescentic glomerulonephritis in a patient with scleroderma without marked dermatological change and malignant hypertension. Intern Med 43:496-502
33. Wigley FM, Hummers LK (2003) Clinical features of systemic sclerosis. In: Hochberg MC, Silman AJ, Smolen JS, Wienblatt ME, Weismann MH (eds) Rheumatology, 3rd ed. Edinburgh, Mosby, pp 1463-1477
34. Mayes MD (2003) Scleroderma epidemiology. Rheum Dis Clin North Am 29:239-254
35. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349:1526-1533
36. Homma S, Matsushita H, Nakata K (2004) Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respirology 9:190-196
37. Lhote F, Cohen P, Genereau T, Gayraud M, Guillevin L (1996) Microscopic polyangiitis: clinical aspects and treatment. Ann Med Interne (Paris) 147:165-177
38. Gaudin PB, Askin FB, Falk RJ, Jennette JC (1995) The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 104:7-16
39. Nada AK, Torres VE, Ryu JH, Lie JT, Holley KE (1990) Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients. Mayo Clin Proc 65:847-856
40. Eschun GM, Mink SN, Sharma S (2003) Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis. Chest 123:297-301
41. Donohoe JF (1992) Scleroderma and the kidney. Kidney Int 41:462-477
42. Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr (1990) Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 113:352-357
43. Steen VD, Medsger TA Jr (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41:1613-1619
44. Khanna D, Aggarwal A, Bhakuni DS, Dayal R, Misra R (2003) Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis. J Rheumatol 30:1248-1252